Orexo AB
OTC:ORXOY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orexo AB
OTC:ORXOY
|
SE |
|
Tooru PLC
LSE:TOO
|
UK |
|
S
|
Shaftesbury Capital PLC
OTC:CCPPF
|
UK |
|
UOB-Kay Hian Holdings Ltd
SGX:U10
|
SG |
|
M
|
Micron Technology Inc
F:MTE
|
US |
|
W W Grainger Inc
NYSE:GWW
|
US |
|
Zenkoku Hosho Co Ltd
F:ZKH
|
JP |
Intrinsic Value
Is ORXOY undervalued or overvalued?
See the intrinsic value estimate for
Orexo AB and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Orexo AB Does
Orexo AB is a Swedish specialty pharmaceutical company that makes and sells medicines, mainly for opioid use disorder and other conditions where drug delivery matters. Its best-known product is Zubsolv, a prescription tablet that doctors use to help patients manage opioid dependence. The company also develops new formulations and delivery technologies that can make medicines easier to take or more reliable to use.
- Headquarters
- Sweden SE
- Employees
- 65
- IPO date
- Nov 9, 2005
Revenue & Expenses Breakdown
Orexo AB
Earnings Waterfall
Orexo AB
The intrinsic value for
Orexo AB (ORXOY) under the Base Case is hidden USD.
Compared with the current market price of 0.443 USD, the stock appears hidden.